Relationship of Synovial Tumor Necrosis Factor α and Interleukin 6 to Temporomandibular Disorder

Journal of Oral and Maxillofacial Surgery

Volumn 68, Issue 5, 2010, Pages 1064-1068

  Lee, Jeong Keun ^a   Cho, Young Sook ^a   Song, Seung Il ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CYTOKINE; INTERLEUKIN 6; LIDOCAINE; TUMOR NECROSIS FACTOR ALPHA;

ARTHROCENTESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATION; JAW MOVEMENT; LAVAGE; MOUTH; PAIN; SOUND; SYMPTOM; SYNOVIAL FLUID; SYNOVITIS; TEMPOROMANDIBULAR JOINT DISORDER;

ACUTE DISEASE; BIOLOGICAL MARKERS; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACIAL PAIN; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; IRRIGATION; PARACENTESIS; RANGE OF MOTION, ARTICULAR; SOUND; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT DISORDERS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950810241     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2009.08.007     Document Type: Article

References (28)

1. Ballegaard V., Thede-Schmidt-Hansen P., Svensson P., et al. Are headache and temporomandibular disorders related?. A blinded study. Cephalalgia 28 (2008) 832
2. Dubner R. The neurobiology of persistent pain and its clinical implications. Suppl Clin Neurophysiol 57 (2004) 3
3. Treede R.-D., Meyer R.A., Raja S.N., et al. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 38 (1992) 397
4. Korean Association of Oral & Maxillofacial Surgeons. Temporomandibular disorder. Textbook of Oral and Maxillofacial Surgery. (ed 2) (2005), Dental and Medical Publishing Co, Seoul, South Korea 553
5. Ash M.M. Current concepts in the aetiology, diagnosis and treatment of TMJ and muscle dysfunction. J Oral Rehabil 13 (1986) 1
6. Egermark I., Magnusson T., and Carlsson G.E. A 20-year follow-up of signs and symptoms of temporomandibular disorders and malocclusions in subjects with and without orthodontic treatment in childhood. Angle Orthod 73 (2003) 109
7. Liljeström M.-R., Le Bell Y., Anttila P., et al. Headache children with temporomandibular disorders have several types of pain and other symptoms. Cephalalgia 25 (2005) 1054
8. Niemi P.M., Le Bell Y., Kylmala M., et al. Psychological factors and responses to artificial interferences in subjects with and without a history of temporomandibular disorders. Acta Odontol Scand 64 (2006) 300
9. Tomida M., Ishimaru J.I., Murayama K., et al. Intra-articular oxidative state correlated with the pathogenesis of disorders of the temporomandibular joint. Br J Oral Maxillofac Surg 42 (2004) 405
10. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 104 (2001) 487
11. Vilcek J., and Lee T. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266 (1991) 7313
12. Wagner R., and Myers R.R. Schwann cells produce tumor necrosis factor alpha: Expression in injured and non-injured nerves. Neuroscience 73 (1996) 625
13. Chen G., and Goeddel D.V. TNF-R1 signaling: A beautiful pathway. Science 296 (2002) 1634
14. Hayden M.S., and Ghosh S. Signaling to NF-κB. Genes Dev 18 (2004) 2195
15. Wright G., Singh I.S., Hasday J.D., et al. Endotoxin stress-response in cardiomyocytes: NF-kappa B activation and tumor necrosis factor-alpha expression. Am J Physiol Heart Circ Physiol 282 (2002) H872
16. Heinrich P.C., Behrmann I., Müller-Newen G., et al. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334 (1998) 297
17. Oka T., Oka K., Hosoi M., et al. Intracerebroventricular injection of interleukin-6 induces thermal hyperalgesia in rats. Brain Res 692 (1995) 123
18. Kaneyama K., Segami N., Sato J., et al. Interleukin-6 family of cytokines as biochemical markers of osseous changes in the temporomandibular joint disorders. Br J Oral Maxillofac Surg 42 (2004) 246
19. Emshoff R., Puffer P., Rudisch A., et al. Temporomandibular joint pain: Relationship to internal derangement type, osteoarthrosis, and synovial fluid mediator level of tumor necrosis factor-α. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 (2000) 442
20. Dinarello C.A. Proinflammatory cytokines. Chest 118 (2000) 503
21. Mastorakos G., and Ilias I. Interleukin-6: A cytokine and/or a major modulator of the response to somatic stress. Ann N Y Acad Sci 1088 (2006) 373
22. Kubota E., Imamura H., Kubota T., et al. Interleukin 1[beta] and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 55 (1997) 20
23. Fu K., Ma X., Zhang Z., et al. Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J Orofac Pain 9 (1995) 131
24. Fu K., Xuchen M.A., Zhang Z., et al. Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg 53 (1995) 424
25. Shafer D.M., Assael L., White L.B., et al. Tumor necrosis factor-α as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J Oral Maxillofac Surg 52 (1994) 786
26. Takahashi T., Kondoh T., Fukuda M., et al. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 135
27. Rozen T., and Swidan S.Z. Elevation of CSF tumor necrosis factor α levels in new daily persistent headache and treatment refractory chronic migraine. Headache 47 (2007) 1050
28. Whiteside T.L. Cytokine measurements and interpretation of cytokine assays in human disease. J Clin Immunol 14 (1994) 327